Catalyst Capital Advisors’s Medtronic MDT Stock Holding History

Catalyst Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Hold	30,550	–	–	0.04%	104
2026 Q1	$2.65M	Hold	30,550	–	–	0.05%	94
2025 Q4	$2.93M	Buy	30,550 +1,225	+4%	+$119K	0.06%	96
2025 Q3	$2.79M	Hold	29,325	–	–	0.06%	99
2025 Q2	$2.56M	Hold	29,325	–	–	0.05%	103
2025 Q1	$2.64M	Hold	29,325	–	–	0.05%	101
2024 Q4	$2.34M	Buy	29,325 +405	+1%	+$35.1K	0.05%	105
2024 Q3	$2.6M	Buy	28,920 +3,120	+12%	+$262K	0.06%	101
2024 Q2	$2.03M	Hold	25,800	–	–	0.05%	114
2024 Q1	$2.25M	Hold	25,800	–	–	0.05%	112
2023 Q4	$2.13M	Buy	25,800 +3,737	+17%	+$285K	0.06%	111
2023 Q3	$1.73M	Hold	22,063	–	–	0.05%	120
2023 Q2	$1.94M	Hold	22,063	–	–	0.06%	120
2023 Q1	$1.78M	Hold	22,063	–	–	0.05%	120
2022 Q4	$1.71M	Buy	22,063 +10,685	+94%	+$866K	0.06%	116
2022 Q3	$918K	Buy	11,378 +5,350	+89%	+$481K	0.03%	127
2022 Q2	$541K	Buy	6,028 +615	+11%	+$62.3K	0.02%	173
2022 Q1	$601K	Buy	+5,413	New	+$572K	0.03%	179
2020 Q1	–	Sell	-62,800	Closed	-$7.13M	–	285
2019 Q4	$7.13M	Buy	62,800 +17,800	+40%	+$1.95M	0.23%	63
2019 Q3	$4.89M	Buy	+45,000	New	+$4.7M	0.16%	76
2019 Q2	–	Sell	-8,650	Closed	-$788K	–	451
2019 Q1	$788K	Buy	+8,650	New	+$774K	0.03%	155
2017 Q3	–	Sell	-14,900	Closed	-$1.24M	–	495
2017 Q2	$1.32M	Sell	14,900 -9,300	-38%	-$784K	0.06%	158
2017 Q1	$1.95M	Buy	+24,200	New	+$1.89M	0.1%	133
2013 Q3	–	Sell	-2,401	Closed	-$124K	–	302
2013 Q2	$124K	Buy	+2,401	New	+$119K	0.1%	218

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Catalyst Capital Advisors's MDT Position: Q2 2026 in Review

Catalyst Capital Advisors held its Medtronic (MDT) position steady in Q2 2026 at 30,550 shares worth $2.39M. The position accounts for 0.04% of the portfolio, ranked #104.

Catalyst Capital Advisors first reported a position in MDT in Q2 2013 and has held it in 24 quarters since. The position peaked at $7.13M in Q4 2019. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Catalyst Capital Advisors held 30,550 shares of Medtronic worth $2.39M as of Q2 2026.
Catalyst Capital Advisors left its Medtronic share count unchanged in Q2 2026.
Medtronic made up 0.04% of Catalyst Capital Advisors's portfolio in Q2 2026, its #104 holding.
Catalyst Capital Advisors first reported a position in Medtronic in Q2 2013 and has held it in 24 quarters since.
Catalyst Capital Advisors's Medtronic position peaked at $7.13M in Q4 2019.
2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Catalyst Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.